SALDISK 50 µg/1 doza+ 250 µg/1 doza prašak inhalata, dozirani বসনিয়া ও হার্জেগোভিনা - ক্রোয়েশীয় - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

saldisk 50 µg/1 doza+ 250 µg/1 doza prašak inhalata, dozirani

salvus bh d.o.o. - flutikazon, Салметерол - prašak inhalata, dozirani - 50 µg/1 doza+ 250 µg/1 doza - 1 doza praška inhalata doziranog sadrži: 50 µg salmeterola (u obliku salmeterolksinafoata) 250 µg flutikazonpropionata

SALDISK 50 µg/1 doza+ 500 µg/1 doza prašak inhalata, dozirani বসনিয়া ও হার্জেগোভিনা - ক্রোয়েশীয় - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

saldisk 50 µg/1 doza+ 500 µg/1 doza prašak inhalata, dozirani

salvus bh d.o.o. - flutikazon, Салметерол - prašak inhalata, dozirani - 50 µg/1 doza+ 500 µg/1 doza - 1 doza praška inhalata, doziranog sadrži: 50 µg salmeterola (u obliku salmeterolksinafoata) 500 µg flutikazonpropionata

SoliPhar 10 mg filmom obložene tablete ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

soliphar 10 mg filmom obložene tablete

pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - solifenacinsukcinat - filmom obložena tableta - 10 mg - urbroj: jedna filmom obložena tableta sadrži 10 mg solifenacinsukcinata

SoliPhar 5 mg filmom obložene tablete ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

soliphar 5 mg filmom obložene tablete

pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - solifenacinsukcinat - filmom obložena tableta - 5 mg - urbroj: jedna filmom obložena tableta sadrži 5 mg solifenacinsukcinata

BroPair Spiromax ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

bropair spiromax

teva b.v. - xinafoate сальметерол, flutikazon propionat - astma - lijekovi za opstruktivne plućne bolesti dišnih putova, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Seffalair Spiromax ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

seffalair spiromax

teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - lijekovi za opstruktivne plućne bolesti dišnih putova, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.